Photo

613-801-3475 / 604-239-0921

...

Ottawa, Vancouver

English

Stuart Bristowe, Ph.D.

Senior Patent Agent

Stuart’s practice focuses on the drafting and prosecution of patent applications in various areas of technology, including telecommunication, electronics, solid-state lighting, computer software, mechanical devices, medical devices and related technologies. He provides strategic IP portfolio counselling and advises clients on patent strategy, portfolio development, invention disclosure, research documentation and inventorship. Stuart works closely with clients to ensure that their patent portfolios support their business objectives. He also corresponds regularly with a wide network of foreign associates to manage the worldwide prosecution of clients’ patent portfolios. Stuart also has extensive experience in the drafting and prosecution of industrial design applications.

Stuart is a registered patent agent in Canada and also has limited recognition to represent Canadians in patent matters before the USPTO. He has been practicing in the intellectual property industry for over 15 years. Stuart splits his time between Ottawa and Vancouver based clients.

Education

  • B.Eng., McGill University

  • M.Eng., McGill University

  • Ph.D., Civil Engineering and Applied Mechanics, McGill University

Professional Involvement

  • BCTIA (British Columbia Technology Industries Association)

Technology Area

cb photo 106 56b90c1f32572

DR. Michael Maskery

Patent Agent


Michael's practice focuses on the patent drafting, prosecution and strategy in a variety of technology fields.MBM read_more_btn

 

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More